NCT04548700 2024-03-07Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCLCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Terminated38 enrolled
NCT01439347 2021-09-09A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALLSpectrum Pharmaceuticals, IncPhase 3 Terminated26 enrolled 7 charts
NCT02404220 2020-01-02Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Gilead SciencesPhase 1/2 Terminated30 enrolled 17 charts
NCT02568683 2019-04-17Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)Gilead SciencesPhase 1/2 Terminated10 enrolled 12 charts
NCT01287741 2019-04-12A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)Hoffmann-La RochePhase 3 Terminated1,418 enrolled 20 charts
NCT01370694 2019-03-15Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)Merck Sharp & Dohme LLCPhase 1 Terminated7 enrolled 7 charts
NCT02855359 2019-03-11Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular LymphomaSeagen Inc.Phase 2 Terminated24 enrolled 10 charts
NCT00960063 2018-08-27A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)Merck Sharp & Dohme LLCPhase 1 Terminated4 enrolled 8 charts
NCT01925612 2018-06-21Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)Seagen Inc.Phase 2 Terminated87 enrolled 18 charts
NCT00562965 2018-01-09Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)PfizerPhase 3 Terminated29 enrolled 14 charts